Assessing real world vaccine effectiveness: A review of Scotland's approach to monitoring human papillomavirus (HPV) vaccine impact on HPV infection and cervical disease

• Published in: Vaccine 2024-08, Vol.42 (21), p.126177, Article 126177
• Main Authors: Cameron, Ross L, Palmer, Tim J, Cuschieri, Kate, Kavanagh, Kimberley, Roy, Kirsty
• Format: Article
• Language: English
• Subjects: Adolescent; Bisexuality; Cancer; Cancer vaccines; Cellular biology; Cervical cancer; Child; Dosage; Effectiveness; Female; Girls; Herd immunity; Histology; HIV; Human immunodeficiency virus; Human papillomavirus; Human Papillomavirus Viruses - immunology; Humans; Immunization; Immunization Programs; Immunology; Impact analysis; Infections; Laboratories; Male; Medical screening; Men; Mortality; Pandemics; Papillomavirus infections; Papillomavirus Infections - epidemiology; Papillomavirus Infections - prevention & control; Papillomavirus vaccines; Papillomavirus Vaccines - administration & dosage; Papillomavirus Vaccines - immunology; Public health; Public health surveillance; Schedules; Scotland; Scotland - epidemiology; Sexual health; Surveillance; Uterine cervical neoplasms; Uterine Cervical Neoplasms - epidemiology; Uterine Cervical Neoplasms - prevention & control; Uterine Cervical Neoplasms - virology; Vaccination - methods; Vaccine efficacy; Vaccine Efficacy - statistics & numerical data; Vaccines; Warts; Women; Womens health
• ISSN: 0264-410X; 1873-2518; 1873-2518
• DOI: 10.1016/j.vaccine.2024.126177

High-risk human papillomavirus (HPV) infections can progress to cervical cancer which is the fourth most common cancer in women globally. In Scotland, the incidence of cervical cancer has a strong socioeconomic deprivation gradient disproportionately affecting women from more deprived areas. An HPV vaccination programme was initiated in Scotland in 2008 targeting girls aged 12–13 years with a catch-up campaign running for the first three years for girls aged up to 18 years. The programme has evolved over the last 16 years with changes in the type of vaccine, dosing schedules and the extension of the programme to boys and gay, bisexual and other men who have sex with men. Vaccine uptake in Scotland has historically been high but has gradually decreased over time and disparities exist in women from more deprived areas of Scotland. The ability to link national immunisation and screening databases in Scotland has allowed direct monitoring of the impact of the HPV vaccine on virological and histological outcomes. Analyses of this linked data have demonstrated real-world evidence of high vaccine effectiveness against HPV infection, cervical disease, and cervical cancer with evidence of herd immunity in unvaccinated women. Continued monitoring is crucial to assess the duration of protection, the impact of vaccine and dosing schedules changes and the emergence of potential type replacement. With the World Health Organisation's aim to eliminate cervical cancer as a public health problem by the next century addressing the inequalities in cervical cancer incidence will be crucial. This will require targeted interventions for women most at risk of cervical cancer to ensure elimination is achieved timely for all women in Scotland.